Effect of the COVID-19 Pandemic on the Pediatric Emergency Department Flow

Andrea Rivera-Sepulveda1, Timothy Maul2,3, Katherine Dong4

  • 1Department of Pediatrics, Division of Emergency Medicine, Nemours Children's Hospital, Orlando, Florida, USA.

Insights

The COVID-19 pandemic significantly decreased pediatric emergency department (PED) visits and altered patient acuity. Understanding these changes is crucial for future pandemic resource allocation in PEDs.

Area of Science:

  • Pediatric Emergency Medicine
  • Public Health
  • Infectious Disease Epidemiology

Background:

  • The coronavirus disease 2019 (COVID-19) pandemic presented unprecedented challenges to healthcare systems globally.
  • Early pandemic phases necessitated rapid adaptation of emergency department (ED) operations to manage patient flow and acuity.

Purpose of the Study:

  • To analyze the impact of the early COVID-19 pandemic on pediatric emergency department (PED) utilization and patient characteristics.
  • To identify changes in chief complaints, patient acuity, and disposition patterns during the initial months of the pandemic.

Main Methods:

  • A cross-sectional study design was employed, analyzing data from January to April, 2016-2020.
  • Pediatric emergency department visit data included total visits, Emergency Severity Index (ESI), disposition, chief complaint, age, provider-to-disposition time (PTD), and length of stay (PED-LOS).
  • Statistical significance was determined using a P-value <0.01.

Main Results:

  • A significant decrease in PED visits, ranging from 24-71%, was observed between March and April 2020.
  • Chief complaints of fever and cough were most prevalent in March 2020.
  • April 2020 saw a shorter mean PED-LOS (123 min vs. 158 min), increased admission rates (14% vs. 8%), a decrease in ESI 4 (10%), and an increase in ESI 3 (8%) (P < 0.001).

Conclusions:

  • The early pandemic negatively impacted PED patient flow, characterized by reduced visits and a higher admission rate potentially indicating increased patient acuity.
  • Understanding pandemic-related shifts in PED utilization and patient factors is vital for optimizing resource allocation and preparedness for future public health crises.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
15
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
17
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
28
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
24
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
15